First Affiliated Hospital Of Guangxi Medical University

This early-phase study tests a new treatment called CLL-1 CAR-T for children aged 3 to 18 with acute myeloid leukemia (AML) that has returned or not responded to standard therapy. The therapy uses the patient's own immune cells, modified to recognize and attack leukemia cells. Th…

This phase 2 trial tests a new treatment for soft tissue sarcoma that combines a special type of radiation with an immunotherapy strategy called PraG (using Toripalimab, GM-CSF, and Thymalfasin). The goal is to see if this combination can shrink tumors or stop them from growing i…

This study tests whether the clot-busting drug tenecteplase can help people who wake up with stroke symptoms but don't know when the stroke started. About 352 adults with moderate to severe stroke will receive either tenecteplase or standard care after a non-contrast CT scan. The…

This study tests whether inhaling tiny particles from stem cells (called exosomes) can prevent or treat severe mouth sores caused by radiation therapy. About 200 head and neck cancer patients getting radiation will receive either the exosome mist or a placebo. The goal is to see …

This study will test a special AI designed for urology (UroMed) to see if it can safely help with patient education and care before surgery. About 1080 adults with kidney stones, enlarged prostate, or bladder cancer will be split into two groups: one gets AI-assisted care, the ot…

This study looks at how well and how safely the clot-busting drug tenecteplase works in very old patients (80 years or older) who have had a stroke. Researchers will track 392 patients for 90 days to see if they recover with little or no disability. The goal is to gather real-wor…